Coca A - Search Results

1

TORAFIC study protocol: torasemide prolonged release versus furosemide in patients with chronic heart failure.

Díez J, Coca A, de Teresa E, Anguita M, Castro-Beiras A, Conthe P, Cobo E, Fernández E; TORAFIC Investigators Group. Díez J, et al. Among authors: coca a. Expert Rev Cardiovasc Ther. 2009 Aug;7(8):897-904. doi: 10.1586/erc.09.74. Expert Rev Cardiovasc Ther. 2009. PMID: 19673667 Clinical Trial.

2

The ACTION study: nifedipine in patients with symptomatic stable angina and hypertension.

Sierra C, Coca A. Sierra C, et al. Among authors: coca a. Expert Rev Cardiovasc Ther. 2008 Sep;6(8):1055-62. doi: 10.1586/14779072.6.8.1055. Expert Rev Cardiovasc Ther. 2008. PMID: 18793108 Review.

3

Role of dihydropyridinic calcium channel blockers in the management of hypertension.

Coca A, Mazón P, Aranda P, Redón J, Divisón JA, Martínez J, Calvo C, Galcerán JM, Barrios V, Roca-Cusachs I Coll A. Coca A, et al. Expert Rev Cardiovasc Ther. 2013 Jan;11(1):91-105. doi: 10.1586/erc.12.155. Expert Rev Cardiovasc Ther. 2013. PMID: 23259449 Review.

4

Manidipine plus delapril in patients with Type 2 diabetes and hypertension: reducing cardiovascular risk and end-organ damage.

Coca A. Coca A. Expert Rev Cardiovasc Ther. 2007 Mar;5(2):147-59. doi: 10.1586/14779072.5.2.147. Expert Rev Cardiovasc Ther. 2007. PMID: 17338661 Review.

5

Trough-to-peak ratio and circadian blood pressure profile after treatment with once-daily extended-release diltiazem, 240 mg, in patients with mild-to-moderate essential hypertension.

Coca A, Sobrino J, Soler J, Módol J, Palos MA, Mínguez A, Esqúe J, Plana J, Cases M, Closas J, de la Sierra A. Coca A, et al. J Cardiovasc Pharmacol. 1997 Mar;29(3):316-22. doi: 10.1097/00005344-199703000-00003. J Cardiovasc Pharmacol. 1997. PMID: 9125668 Clinical Trial.

6

Management of hypertension in diabetic patients: outstanding issues.

Camafort-Babkowski M, Barrios V, Coca A. Camafort-Babkowski M, et al. Among authors: coca a. Expert Rev Cardiovasc Ther. 2011 Jun;9(6):721-8. doi: 10.1586/erc.11.77. Expert Rev Cardiovasc Ther. 2011. PMID: 21714603 Review.

7

Use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in clinical practice.

Barrios V, Coca A, Escobar C, Enrique R, Rincón LM. Barrios V, et al. Among authors: coca a. Expert Rev Cardiovasc Ther. 2012 Feb;10(2):159-66. doi: 10.1586/erc.11.185. Expert Rev Cardiovasc Ther. 2012. PMID: 22292872

8

A multicenter, parallel comparative study of the antihypertensive efficacy of once-daily lisinopril vs enalapril with 24-h ambulatory blood pressure monitoring in essential hypertension.

Coca A, Sobrino J, Módol J, Soler J, Mínguez A, Plana J, De la Sierra A. Coca A, et al. J Hum Hypertens. 1996 Dec;10(12):837-41. J Hum Hypertens. 1996. PMID: 9140792 Clinical Trial.

9

Comparative evaluation of the antihypertensive efficacy of once-daily amlodipine versus nitrendipine with 24-hour ambulatory blood pressure monitoring in essential hypertension.

Coca A, Picado MJ, De la Sierra A, Aguilera MT, Sánchez M, Lluch MM, Urbano-Márquez A. Coca A, et al. J Cardiovasc Pharmacol. 1993 Oct;22(4):513-8. doi: 10.1097/00005344-199310000-00002. J Cardiovasc Pharmacol. 1993. PMID: 7505351 Clinical Trial.

10

Trough-to-peak ratio, smoothness index, and circadian blood pressure profile after treatment with once-daily fixed combination of losartan 100 and hydrochlorothiazide 25 in essential hypertension.

Coca A, Sobrino J, Soler J, Felip A, Pelegrí A, Mínguez A, Vila J, de la Sierra A, Plana J. Coca A, et al. J Cardiovasc Pharmacol. 2002 Jun;39(6):824-33. doi: 10.1097/00005344-200206000-00007. J Cardiovasc Pharmacol. 2002. PMID: 12021576

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

557 results

Search Page